Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-20

Clinical Trial Update: Effect of Compound (Cardiol Forte) on Lipid And Glycemic Parameters in Low Cardiovascular Risk Individuals [NA]

View source ↗

Summary

This clinical trial investigates the effect of Cardiol Forte on lipid and glycemic parameters in individuals at low cardiovascular risk with dyslipidemia. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cardiol Forte

Snippet

Sponsor: U.G.A. Nutraceuticals | Conditions: Dyslipidemia | NA | Status: NOT_YET_RECRUITING